Drug Developer’s Fraud, Trade Secret Claims Survive Competitor’s Dismissal Bid
CHICAGO — In a May 13 opinion, a federal judge in Illinois ruled that a drug development company pleaded with sufficient particularity that it took reasonable efforts to maintain the secrecy...To view the full article, register now.
Already a subscriber? Click here to view full article